Original Article by Amber Tong and Laura Curtis Bloomberg | 22 July 2026
Generic drug tariffs could raise US medicine costs, disrupt global supply chains and pressure manufacturers to move production to America.
AI Image | Chat-GPT
US President Donald Trump has announced steep tariffs on imported generic medicines. The move is designed to encourage pharmaceutical manufacturers to relocate production to the United States.
Trump said generic medicines would remain tariff-free for two years from 1 August 2026. A 100% tariff would then apply for one year from August 2028. This would increase to 200% from August 2029.
PEPFAR cuts have been linked to a 45% decline in South African children receiving HIV treatment at US-supported healthcare sites.
Read more...
Fake medical certificates are driving sick leave abuse in South Africa, costing employers through absenteeism, fraud and lost productivity.
Read more...
Aspen Semaglutide Canada gains Health Canada approval, but API supply problems could delay the generic’s commercial launch.
Read more...